In a study comparing a group of young patients (< 50 years old) with pancreatic cancer with a group with the usual age, the younger group had a higher proportion of the nonmutated KRAS gene than the older group (17% vs. 4%) [65]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.